- On November 7, 2018
On October 30, the U.S Food and Drug Administration (FDA) released a plan to “advance plant and animal biotechnology innovation”.
The plan identifies priorities in three areas: 1) advancing human and animal health by promoting product innovation and applying modern, efficient and risk-based regulatory pathways; 2) strengthening public outreach and communication regarding the FDA’s approach to innovative plant and animal biotechnology; and 3) increasing engagement with domestic and international partners on biotechnology issues.
“We’re encouraged by FDA’s announcement that the agency is moving forward on a plan to provide clarity and foster future innovation around evolving plant breeding methods,” said ASTA President & CEO Andrew LaVigne.
View ASTA’s full statement here.